ADVERTISEMENTREMOVE AD

Immunotherapy Safe For COVID-19 Cancer Patients, Says Study

Updated
Coronavirus
2 min read
story-hero-img
i
Aa
Aa
Small
Aa
Medium
Aa
Large
Hindi Female

Researchers have now shown that immunotherapy doesn't necessarily worsen complications for patients with both Covid-19 and cancer.

“Many Covid-19 complications result from an overactive immune response, leading to an increased production of proteins called cytokines.”
Study researcher Layne Weatherford from the University of Cincinnati (UC)

"Increased production of these proteins can cause issues like respiratory failure. Patients with cancer are more susceptible to Covid-19 infection as well as severe complications from it," Weatherford added.

ADVERTISEMENTREMOVE AD

According to the researchers, many patients with cancer are treated with immunotherapy, which activates the immune system against cancer to destroy it. In patients with both Covid-19 and cancer, the research team thought that immunotherapy might increase the immune system response, which could already be overactive because of the Covid-19 infection.

They thought treating Covid-19 patients with cancer immunotherapy might result in worsening patients' health and overall outcomes.

“We are continuing to investigate whether immunotherapy causes an increased production of these proteins by immune cells from Covid-19 patients, but our initial findings are showing that immunotherapy is not significantly impacting it.” 
Study researcher Wise-Draper

Researchers have conducted this study using blood samples from patients with cancer taken from the UC Covid-19 biorepository. "We examined how immune checkpoint inhibitors, drugs that allow immune cells to respond more strongly, in combination with other treatments, like chemotherapy or radiation, affect the immune cells of Covid-19 patients and patients with both Covid-19 and cancer," she said.

The preliminary data show that an anti-diabetic drug, metformin, can reduce the production of these proteins by immune cells of Covid-19 patients.

"These are promising, initial findings. Additional research is needed, but our results show that we might be able to treat Covid-19 complications with metformin or a similar drug one day," the study authors noted.

(This story was published from a syndicated feed. Only the headline and picture has been edited by FIT)

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

0

Read Latest News and Breaking News at The Quint, browse for more from fit and coronavirus

Topics:  Cancer   Immunotherapy   coronavirus 

Published: 
Speaking truth to power requires allies like you.
Become a Member
3 months
12 months
12 months
Check Member Benefits
Read More
×
×